TGFB1 and Peritoneal Fibrosis: In the context of the wide application of biocompatible peritoneal dialysis solutions, high concentrations of glucose, glucose degradation products (GDP) and advanced glycation end products (AGEs) can induce the production of TGF-β and promote the occurrence and development of peritoneal fibrosis.